Contact this trialFirst, we need to learn more about you.
CDK4/6 Inhibitor
Abemaciclib Combo for Lung Cancer or alternatively, if focusing on breast cancer: Abemaciclib Combo for Breast Cancer
Recruiting1 awardPhase 1
Fayetteville, Arkansas
This trial is testing a new cancer drug combo to see if it's safe and effective against NSCLC and HR+ breast cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.